Although African Americans with high-risk APOL1 genotypes have the highest risk of developing idiopathic FSGS and HTN-attributed ESKD,3,4,9 they are underrepresented in clinical trials of therapeutic agents.36 Here, APOL1 is linked to focal segmental glomerulosclerosis.